FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula I or a physiologically acceptable salt of said compound, where X is a (C1-C6)-alkanediiyloxy group, wherein oxygen atom of (C1-C6)-alkanediiyloxy group is bonded with a group Y; Y represents phenylene, where phenylene, at one or more carbon ring atoms, can optionally be substituted with identical or different substitutes R5; R1 represents hydrogen; R2 and R3 independently denote H or halogen; R5 represents a (C1-C4)-alkyl. Invention also relates to a pharmaceutical composition for activation of EDG-1 receptor, containing at least one compound of formula I or one physiologically acceptable salt of said compound and a pharmaceutically acceptable carrier.
EFFECT: technical result is derivatives of carboxylic acids with oxazole[4,5-c]pyridine cycle for use as a medicinal agent for EDG-1 receptor activation.
4 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF CARBOXYLIC ACIDS WITH OXAZOLE[5,4-b]PYRIDINE RING | 2012 |
|
RU2609002C2 |
| CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5,7-SUBSTITUTED OXAZOLE PYRIMIDINE RING | 2011 |
|
RU2560876C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS WITH OXAZOLE[5,4-d]PYRIMIDINE CYCLE | 2012 |
|
RU2609008C2 |
| HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2559896C2 |
| DERIVATIVE OF HETEROCYCLIC CARBON ACIDS, WHICH CONTAIN 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2554869C2 |
| HETEROARYL-SUBSTITUTED AMIDES CONTAINING SATURATED BINDING GROUP AND USE THEREOF AS PHARMACEUTICAL AGENTS | 2006 |
|
RU2412181C2 |
| 2,5,7-SUBSTITUTED OXAZOLPYRIMIDINE DERIVATIVES | 2011 |
|
RU2557246C2 |
| IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696275C1 |
| IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
